EMPIRICO Trademark

Trademark Overview


On Monday, December 31, 2018, a trademark application was filed for EMPIRICO with the United States Patent and Trademark Office. The USPTO has given the EMPIRICO trademark a serial number of 88977640. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 25, 2023. This trademark is owned by Empirico Inc.. The EMPIRICO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal system, diseases of aging, diseases of the blood, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, psychiatric diseases, allergic diseases and infectious diseases; pharmaceutical preparations for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry, particularly for preventing or treating diseases...
empirico

General Information


Serial Number88977640
Word MarkEMPIRICO
Filing DateMonday, December 31, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 25, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 30, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal system, diseases of aging, diseases of the blood, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, psychiatric diseases, allergic diseases and infectious diseases; pharmaceutical preparations for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry, particularly for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal system, diseases of aging, diseases of the blood, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, psychiatric diseases, allergic diseases and infectious diseases; pharmaceutical preparations for use in pediatric, geriatric, emergency, family, and preventative medicine, particularly for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal system, diseases of aging, diseases of the blood, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, psychiatric diseases, allergic diseases and infectious diseases; pharmaceutical preparations for the treatment of infectious, deficiency, hereditary, and physiological diseases
Translation of Words in MarkThe English translation of "EMPIRICO" in the mark is "EMPIRICAL".

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 23, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEmpirico Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122

Party NameEmpirico Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122

Trademark Events


Event DateEvent Description
Monday, September 25, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 25, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, January 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 19, 2023SOU EXTENSION 5 GRANTED
Tuesday, January 17, 2023SOU EXTENSION 5 FILED
Tuesday, January 17, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 3, 2022SOU EXTENSION 4 GRANTED
Wednesday, August 3, 2022SOU EXTENSION 4 FILED
Wednesday, August 3, 2022SOU TEAS EXTENSION RECEIVED
Thursday, February 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 1, 2022SOU EXTENSION 3 GRANTED
Tuesday, February 1, 2022SOU EXTENSION 3 FILED
Tuesday, February 1, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 10, 2021ASSIGNED TO EXAMINER
Friday, August 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 4, 2021SOU EXTENSION 2 GRANTED
Wednesday, August 4, 2021SOU EXTENSION 2 FILED
Wednesday, August 4, 2021SOU TEAS EXTENSION RECEIVED
Saturday, January 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 28, 2021SOU EXTENSION 1 GRANTED
Thursday, January 28, 2021SOU EXTENSION 1 FILED
Thursday, January 28, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, August 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 30, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 27, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 28, 2020DIVISIONAL PROCESSING COMPLETE
Friday, April 3, 2020DIVISIONAL REQUEST RECEIVED
Tuesday, April 28, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 7, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 6, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 6, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 3, 2020TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, October 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 8, 2019NON-FINAL ACTION E-MAILED
Tuesday, October 8, 2019NON-FINAL ACTION WRITTEN
Friday, September 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 12, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 20, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 20, 2019NON-FINAL ACTION E-MAILED
Wednesday, March 20, 2019NON-FINAL ACTION WRITTEN
Wednesday, March 20, 2019ASSIGNED TO EXAMINER
Wednesday, January 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 3, 2019NEW APPLICATION ENTERED